Alternative Data for Integra Lifesciences
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 136 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 73,000 | Sign up | Sign up | Sign up |
| Employee Rating | 60 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 31 | Sign up | Sign up | Sign up |
| Facebook Followers | 1,371 | Sign up | Sign up | Sign up |
| Instagram Followers | 2,160 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 368 | Sign up | Sign up | Sign up |
| X Followers | 2,058 | Sign up | Sign up | Sign up |
| X Mentions | 14 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 30 | Sign up | Sign up | Sign up |
| Linkedin Employees | 3,877 | Sign up | Sign up | Sign up |
About Integra Lifesciences
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care and otolaryngology.
| Price | $9.17 |
| Target Price | Sign up |
| Volume | 1,113,915 |
| Market Cap | $744M |
| Year Range | $9.17 - $16.12 |
| Dividend Yield | 0% |
| PE Ratio | 83.17 |
| Analyst Rating | 13% buy |
| Industry | Medical Devices |
In the news
 |
Integra LifeSciences Holdings Corporation (IART) Presents at 44th Annual J.P. Morgan Healthcare Conference - SlideshowJanuary 21 - SeekingAlpha |
|
Integra LifeSciences Holdings Corporation (IART) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptJanuary 14 - SeekingAlpha |
 |
Global Minimally Invasive Surgical Devices Market to Witness Upsurge in Growth at a CAGR of ~7% by 2034 | DelveInsightMarch 11 - PR Newswire UK |
 |
Wound and Burn Dressing Recall: Integra LifeSciences Removes Certain MediHoney and CVS Wound and Burn ProductsMarch 5 - FDA.gov |
Dermal Fillers Market Set to Surpass USD 17.21 Billion by 2035, Fueled by Rising Demand for Minimally Invasive Aesthetic Procedures – SNS InsiderMarch 2 - GlobeNewswire |
|
Integra LifeSciences shares are trading lower. The company reported Q4 financial results and issued Q1 guidance below estimates. The company also announced FY26 guidance.February 25 - Benzinga |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 402M | 176M | 226M | -5.4M | 54M | 0.540 |
| Q2 '25 | 416M | 206M | 209M | -484M | -472M | 0.450 |
| Q1 '25 | 383M | 171M | 211M | -25M | -15M | -0.331 |
| Q4 '24 | 443M | 194M | 249M | 19M | 79M | 0.970 |
| Q3 '24 | 381M | 194M | 187M | -11M | 39M | 0.410 |
Insider Transactions View All
| GRAVES JEFFREY A filed to buy 41,086 shares at $11.4. November 6 '25 |
| Schwartz Eric filed to sell 59,511 shares at $24.6. December 4 '24 |
| McBreen Michael J. filed to sell 56,182 shares at $24.2. December 3 '24 |
| Mosebrook Jeffrey filed to sell 36,088 shares at $21.6. August 20 '24 |
| ESSIG STUART filed to buy 487,922 shares at $28.5. May 24 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Josh Gottheimer |
Jul 9, 24 | Sell | $1K - $15K |
| Joshua Gottheimer Democrat |
May 15, 24 | Sell | $1K - $15K |
Read more about Integra Lifesciences (IART) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Integra Lifesciences
The Market Cap of Integra Lifesciences is $744M.
As of today, Integra Lifesciences' PE (Price to Earnings) ratio is 83.17.
Currently, the price of one share of Integra Lifesciences stock is $9.17.
The IART stock price chart above provides a comprehensive visual representation of Integra Lifesciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Integra Lifesciences shares. Our platform offers an up-to-date IART stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Integra Lifesciences (IART) does not offer dividends to its shareholders. Investors interested in Integra Lifesciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Integra Lifesciences are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
